As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...
CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high.
CVS Health Corporation (NYSE:CVS) is a retailer that operates in four segments: health care benefits, health services, ...
Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...
CVS Health’s total revenue for the full year 2024 increased 4.2% to $372.8 billion, but within the healthcare benefits ...
CVS Health posted stronger-than-expected fourth quarter earnings Wednesday, including a narrowing of its key benefit-expense ...
Troubled drugstore chain CVS Health (CVS) reported Fiscal fourth-quarter results that beat on the top and bottom lines, ...
It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain ...
CVS has replaced its CEO, and is working to reassure investors. The stock has jumped more than 20% in the first weeks of 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results